Immune reactions in the rheumatoid synovial tissue

  • L. Klareskog
  • H. Wigzell

Abstract

For the understanding of the immunopathogenic process in the rheumatoid synovial tissue, there are two issues that are of particular interest: (i) which regulatory and effector mechanisms are involved in the formation of the rheumatic lesions and, most importantly, (ii) what is the specificity (specificities) of the immune reactions responsible for the subsequent development of the multiple immunological and inflammatory events that can be observed in the joints of individuals with advanced rheumatoid arthritis (RA).

Keywords

Rheumatoid Arthritis Rheumatoid Factor Synovial Tissue Synovial Cell Juvenile Rheumatoid Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Soren, A. (1978). Histodiagnosis and Clinical Correlations of Rheumatoid and other Synovitis. (Stuttgart: George Thieme Publishers)Google Scholar
  2. 2.
    Smiley, J.O., Sachs, C. and Ziff, M. (1968). In vitro synthesis of immunoglobulins by rheumatoid synovial membrane. J. Clin. Invest., 47, 624–32PubMedCrossRefGoogle Scholar
  3. 3.
    Abrahamsen, T.G., Fröland, S.S., Natvig, J.B. and Pahle, J. (1975). Elution and characterization of lymphocytes from rheumatoid inflammatory tissue. Scand. J. Immunol., 4, 823–30PubMedGoogle Scholar
  4. 4.
    VanBoxel, J.A. and Paget, V.A. (1975). Predominantly T-cell infiltrate in rheumatoid synovial membranes. N. Engl. J. Med., 293, 517–21CrossRefGoogle Scholar
  5. 5.
    Klareskog, L., Forsum, U., Scheynius, A., Kabelitz, D. and Wigzell, H. (1982). Evidence in support of a self-perpetuated HLA-DR dependent delayed type cell reaction in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 79, 3632–6PubMedCrossRefGoogle Scholar
  6. 6.
    Scheynius, A., Klareskog, L. and Forsum, U. (1982). In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin. Exp. Immunol., 49, 325–30PubMedGoogle Scholar
  7. 7.
    Hanafusa, T., Pujol-Borrell, P., Ciovato, L., Russell, R.C.G., Doniach, D. and Bottazzo, G.F. (1983). Aberrant expression of HLA-DR antigen on thyrocytes in Graves disease: relevance for autoimmunity. Lancet, ii, 1111–15CrossRefGoogle Scholar
  8. 8.
    Jansson, R., Karlsson, A. and Forsum, U. (1984). Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves thyreotoxicosis, Hashimoto’s thyreoiditis and nodular colloid goitre. Clin. Exp. Immunol., 58, 264–72PubMedGoogle Scholar
  9. 9.
    Olsson, T., Henriksson, K.G., Klareskog, L. and Forsum, U. (1985). HLA-DR expression, T lymphocyte phenotypes, OKMl and OKT9 reactive cells in inflammatory myopathy. Muscle Nerve, 8, 419–25PubMedCrossRefGoogle Scholar
  10. 10.
    Lindahl, G., Hedfors, E., Klareskog, L. and Forsum, U. (1985). Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjogren’s syndrome. Clin. Exp. Immunol., 61, 475–82PubMedGoogle Scholar
  11. 11.
    Adamson, T., Fox, R., Frisman, D. and Howell, F. (1983). Immunohistological analysis of lymphoid infiltrates in primary Sjogren’s syndrome using monoclonal antibodies. J. Immunol., 130, 203–8PubMedGoogle Scholar
  12. 12.
    Klareskog, L., Forsum, U., Malmnäs-Tjernlund, U., Kabelitz, D. and Wigren, A. (1981). Appearance of anti-HLA-DR reactive cells in normal and rheumatoid synovium. Scand. J. Immunol., 14, 183–92PubMedCrossRefGoogle Scholar
  13. 13.
    Janossy, G., Panayi, G., Duke, O., Bofill, M., Poulter, L.W. and Goldstein, G. (1981). Rheumatoid arthritis: a disease of T lymphocyte macrophage immunoregulation. Lancet, ii, 839–43CrossRefGoogle Scholar
  14. 14.
    Klareskog, L., Johnell, O. and Hulth, A. (1984). Expression of HLA-DR and HLA-DQ antigens on cells within the cartilage-pannus junction in rheumatoid arthritis. Rheumatol. Int., 4 (Suppl.), 11–15PubMedCrossRefGoogle Scholar
  15. 15.
    Klareskog, L., Johnell, O., Hulth, A., Holmdahl, R. and Rubin, K. (1986). Reactivity of monoclonal anti-collagen II antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. Arthr. Rheum., 29, 730–40CrossRefGoogle Scholar
  16. 16.
    Winchester, RJ. and Burmester, G. (1981). Demonstration of la antigens on certain dendritic cells and on a novel elongated cell found in human synovial tissues. Scand. J. Immunol., 14, 441–7CrossRefGoogle Scholar
  17. 17.
    Klareskog, L., Forsum, U., Kabelitz, D., Plöen, L., Sundström, C., Nilsson, K., Wigren, A. and Wigzell, H. (1982). Immune functions of human synovial cells: phenotypic and T-cell regulatory properties of macrophage-like cells that express HLA-DR. Arthr. Rheum., 25, 488–501CrossRefGoogle Scholar
  18. 18.
    Burmester, G.R., Dimitriu-Bona, A., Watares, S.J. and Winchester, R.J. (1983). Identification of three major synovial cell populations by monoclonal antibodies directed to la antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand. J. Immunol., 17, 69–82PubMedCrossRefGoogle Scholar
  19. 19.
    Steinman, R.M. and Nussenzweig, M.C. (1980). Dendritic cells: features and functions. Immunol. Rev., 53, 125–48CrossRefGoogle Scholar
  20. 20.
    Unanue, E.R. (1984). Antigen-presenting function of the macrophage. Annu. Rev. Immunol., 2, 395–428PubMedCrossRefGoogle Scholar
  21. 21.
    Stingl, G., Tamaki, K., Katz, S.I. (1980). Origin and function of epidermal Langerhans cells. Immunol. Rev., 53, 149–74PubMedCrossRefGoogle Scholar
  22. 22.
    Burmester, G.R., Yu, D.T.Y., Irani, A.M., Kunkel, H.G. and Winchester, R.J. (1982). Ia + T-cells in synovial fluid and tissue of patients with rheumatoid arthritis. Arthr. Rheum., 24, 1370–6CrossRefGoogle Scholar
  23. 23.
    Förre, Ö., Egeland, T.G., Dobloug, J.H., Kvien, T.K. and Natvig, J.B. (1982). Autologous mixed lymphocyte reactions in patients with rheumatoid arthritis and juvenile rheumatoid arthritis: both non-T and in vivo activated T cells can act as stimulator cells. Scand. J. Immunol., 16, 173–9PubMedCrossRefGoogle Scholar
  24. 24.
    Klareskog, L., Forsum, U., Wigren, A. and Wigzell, H. (1982). Relationships between HLA-DR expressing cells and T lymphocytes of different subsets in rheumatoid synovial tissue. Scand. J. Immunol., 15, 501–7CrossRefGoogle Scholar
  25. 25.
    Förre, Ö., Thoen, J., Lea, T., Dobloug, J.H., Mellbye, O.J., Natvig, J.B., Pahle, J. and Solheim, B.G. (1982). In situ characterization of mononuclear cells in rheumatoid tissues using monoclonal antibodies. Scand. J. Immunol., 16, 315–19PubMedCrossRefGoogle Scholar
  26. 26.
    Engleman, E.G., Benike, C.J., Grumet, F.C. and Evans, R.L. (1981). Activation of human T lymphocyte subsets: Helper and suppressor/cytotoxic T-cells recognize and respond to distinct histocompatibility antigens. J. Immunol., 127, 2124–9PubMedGoogle Scholar
  27. 27.
    Lindblad, S., Klareskog, L., Hedfors, E., Forsum, U. and Sundström, C (1983). Phenotypic characterization of synovial tissue in situ in different types of synovitis. Arthr. Rheum., 26, 1321–32CrossRefGoogle Scholar
  28. 28.
    Scheynius, A., Fischer, T., Forsum, U. and Klareskog, L. (1984). Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin. Exp. Immunol., 55, 81–90PubMedGoogle Scholar
  29. 29.
    Johnell, O., Hulth, A. and Henriksson, A. (1986). T-lymphocyte subsets and HLA-DR expressing cells in the osteoarthritic synovialis. Scand. J. Rheumatol. (In press)Google Scholar
  30. 30.
    Malone, D.G., Wahl, S.M., Tsokos, M, Cattell, H., Decker, J.L. and Wilder, R.L. (1984). Immune function in severe active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohisto-logic characteristics. J. Clin. Invest., 74, 1173–85PubMedCrossRefGoogle Scholar
  31. 31.
    Lindblad, S. and Hedfors, E. (1985). Intra-articular variation in synovitis. Local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthr. Rheum., 28, 977–86CrossRefGoogle Scholar
  32. 32.
    Barland, P., Novikoff, A.B. and Hamerman, D. (1962). Electron microscopy of the human synovial membrane. J. Cell Biol., 14, 207–30PubMedCrossRefGoogle Scholar
  33. 33.
    Shiozawa, S., Shiozawa, K. and Fujita, T. (1983). Presence of HLA-DR antigen on synovial type A and B cells: an immuno-electron microscopic study in rheumatoid arthritis, osteoarthritis and normal traumatic joints. Immunology, 50, 587–94PubMedGoogle Scholar
  34. 34.
    Iguchi, T., Kurosaka, M. and Ziff, M. (1986). Electron microscopic study of HLA-DR and monocyte/macrophage staining cells in the rheumatoid synovial membrane. Arthr. Rheum., 29, 600–13CrossRefGoogle Scholar
  35. 35.
    Poulter, L.W., Duke, O., Hobbs, S., Janossy, G. and Panai, G. (1982). Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining. Clin. Exp. Immunol., 48, 381–8PubMedGoogle Scholar
  36. 36.
    Burmester, G.R., Locher, P., Koch, B., Winchester, R.J., Dimitriu-Bona, A., Kalden, J.R. and Mohr, W. (1983). The tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases. Rheumatol. Int., 3, 173–81PubMedCrossRefGoogle Scholar
  37. 37.
    Poulter, L.W., Duke, O., Hobbs, S., Janossy, G., Panayi, G. and Seymour, G. (1983). The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis. Clin. Exp. Immunol., 51, 247–54PubMedGoogle Scholar
  38. 38.
    Kurosaka, M. and Ziff, M. (1983). Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J. Exp. Med., 158, 1191–210PubMedCrossRefGoogle Scholar
  39. 39.
    Fraser, J.R.E. and McCall, J.F. (1965). Culture of synovial cells in vitro. Notes on isolation and propagation. Ann. Rheum. Dis., 24, 351–9PubMedCrossRefGoogle Scholar
  40. 40.
    Klareskog, L., Forsum, U. and Wigzell, H. (1982). Murine synovial intima contains I-A, I-E/C positive bone-marrow derived cells. Scand. J. Immunol., 15, 508–13Google Scholar
  41. 41.
    Klareskog, L., Holmdahl, R., Rubin, K., Victorin, A. and Lindgren, J.A. (1985). Different populations of rheumatoid adherent cells mediate activation versus suppression of T lymphocyte proliferation. Arthr. Rheum., 28, 863–72CrossRefGoogle Scholar
  42. 42.
    Waalen, K., Thoen, J., Förre, Ö., Hovig, T., Teigland, J. and Natvig, J.B. (1986). Rheumatoid synovial dendritic cells as stimulators in allogeneic and autologous mixed leucocyte reactions — comparisons with autologous monocytes as stimulator cells. Scand. J. Immunol., 23, 233–41PubMedCrossRefGoogle Scholar
  43. 43.
    Zvaifler, N.J., Steinman, R.M., Kaplan, G., Lau, L.L. and Rivelis, M. (1985). Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J. Clin. Invest., 76, 789–800PubMedCrossRefGoogle Scholar
  44. 44.
    Van Voorhis, W.C., Hair, L.S., Steinman, R.M. and Kaplan, G. (1982). Human dendritic cells: enrichment and characterization from peripheral blood. J. Exp. Med., 155, 1172–87PubMedCrossRefGoogle Scholar
  45. 45.
    Hirschberg, H., Braathen, L. and Thorsby, E. (1982). Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol. Rev., 66 57–77PubMedCrossRefGoogle Scholar
  46. 46.
    Geppert, T.D. and Lipsky, P.E. (1985). Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable la expression. J. Immunol., 135, 3750–62PubMedGoogle Scholar
  47. 47.
    Metzger, Z., Hoffeld, J.T. and Oppenheim, J.J. (1980). Macrophage-mediated suppression I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol., 124, 983–8PubMedGoogle Scholar
  48. 48.
    Stastny, P. (1976). Mixed lymphocyte cultures in rheumatoid arthritis. J. Clin. Invest., 57, 1148–57PubMedCrossRefGoogle Scholar
  49. 49.
    Stastny, P. (1978). Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med., 298, 869–71PubMedCrossRefGoogle Scholar
  50. 50.
    Peterson, P.A. and Rask, L. (1986). Genes and antigens of the HLA-D region. In Solheim, B.G., Möller, E. and Ferrone, S. (eds.) HLA class II Antigens. A Comprehensive Review of Structure and Function, pp. 1–14. (Berlin, Heidelberg: Springer-Verlag)Google Scholar
  51. 51.
    Jeannet, M. (1986). Class II HLA antigens in autoimmune and immune-mediated diseases. In Solheim, B.G., Möller, E. and Ferrone, S. (eds.) HLA class II Antigens. A Comprehensive Review of Structure and Function, pp. 489–514. (Berlin, Heidelberg: Springer-Verlag)Google Scholar
  52. 52.
    Nepom, B.S., Palmer, J., Kim, S.J., Hansen, J.A., Holbeck, S.L. and Nepom, G.T. (1986). Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J. Exp. Med., 164, 345–50PubMedCrossRefGoogle Scholar
  53. 53.
    Goronzy, J., Wey and, C.M. and Garrison Fathman, C. (1986). Shared T cell recognition sites on human histocompatibility leucocyte antigen class II molecules of patients with seropositive rheumatoid arthritis. J. Clin. Invest., 77, 1042–9PubMedCrossRefGoogle Scholar
  54. 54.
    Holoshitz, J., Klajman, A., Drucker, I., Lapidot, Z., Yaretzky, A., van Eden, W. and Cohen, LR. (1986). T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet, ii, 305–9CrossRefGoogle Scholar
  55. 55.
    Jasin, H.E. (1985). Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthr. Rheum., 28, 241–8CrossRefGoogle Scholar
  56. 56.
    Munthe, E. and Natvig, J.B. (1972). Immunoglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin. Exp. Immunol., 12, 55–70PubMedGoogle Scholar
  57. 57.
    Fehr, K., Velvart, M., Rauber, M., Knöpfel, M., Baici, A., Salgam and Boni, A. (1981). Production of agglutinators and rheumatoid factors in plasma cells of rheumatoid and non-rheumatoid synovial tissue. Arthr. Rheum., 24, 510–19CrossRefGoogle Scholar
  58. 58.
    Egeland, T., Lea, T., Saari, G., Mellbye, O.J. and Natvig, J.B. (1982). Quantitation of cells secreting rheumatoid factors of IgG, IgA and IgM class after elution from rheumatoid synovial tissue. Arthr. Rheum., 25, 1445–53CrossRefGoogle Scholar
  59. 59.
    Klareskog, L., Rubin, K. and Holmdahl, R. (1986). Binding of collagen type II to rheumatoid synovial cells. Scand. J. Immunol., 24, 705–14Google Scholar
  60. 60.
    Andrioupolos, N.A., Mestecky, J., Wright, G.P. and Miller, E.J. (1976). Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthr. Rheum., 19, 613–17CrossRefGoogle Scholar
  61. 61.
    Clague, R.B., Firth, S.A., Lennox Holt, P.J., Skingle, J., Greenbury, C.L. and Webley, M. (1983). Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann. Rheum. Dis., 42, 537–44PubMedCrossRefGoogle Scholar
  62. 62.
    Pereira, R.S., Black, C.M., Duance, V.C, Jones, V.E., Jacoby, R.K. and Welsh, K.I. (1985). Disappearing collagen antibodies in rheumatoid arthritis. Lancet, ii, 501–2CrossRefGoogle Scholar
  63. 63.
    Klareskog, L., Holmdahl, R., Larsson, E. and Wigzell, H. (1983). Role of T lymphocytes in collagen II induced arthritis in rats. Clin. Exp. Immunol., 51, 117–25PubMedGoogle Scholar
  64. 64.
    Holmdahl, R., Rubin, K., Klareskog, L., Dencker, L., Gustafson, G. and Larsson, E. (1985). Appearance of different lymphoid cells in synovial tissue and in peripheral blood during the course of collagen II induced arthritis in rats. Scand. J. Immunol., 21, 197–204Google Scholar
  65. 65.
    Larsson, P., Holmdahl, R., Dencker, L. and Klareskog, L. (1985). In vivo treatment with W3/13 (anti-pan T) but not with Ox8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology, 56, 383–91PubMedGoogle Scholar
  66. 66.
    Kohashi, O., Pearson, C.M., Tamaoki, N., Tanaka, A., Shimamura, K., Ozawa, A., Kotani, S., Saito, M. and Hioki, K. (1981). Role of thymus for N-acetyl-muramyl-l-alanyl-d-isoglutamin-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats. Infect. Immunol., 31, 758–66Google Scholar
  67. 67.
    Ranges, G.E., Sririam, S. and Cooper, S.M. (1985). Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med., 162, 1105–10PubMedCrossRefGoogle Scholar
  68. 68.
    Holmdahl, R., Klareskog, L., Rubin, K., Larsson, E. and Wigzell, H. (1985). T lymphocytes in collagen II induced arthritis in mice. Characterization of arthritogenic collagen II specific T cells lines and clones. Scand. J. Immunol., 22, 295—306PubMedGoogle Scholar
  69. 69.
    Holoshitz, J., Naparstek, Y., Ben-Nun, A. and Cohen, I.R. (1984). Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J. Clin. Invest., 73, 211–15PubMedCrossRefGoogle Scholar
  70. 70.
    Van Eden, W., Holoshitz J., Nevo, Z., Frenkel, A., Klajman, A. and Cohen, I.R. (1985). Arthritis induced by a T lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natl. Acad. Sci. USA, 82, 5117–20PubMedCrossRefGoogle Scholar
  71. 71.
    Stuart, J.M. and Dixon, F.J. (1982). Serum transfer of collagen-induced arthritis in mice. J. Exp. Med., 158, 378–92CrossRefGoogle Scholar
  72. 72.
    Taurog, J.D., Kerwar, S.S., McReynolds, R.A., Sandberg, G.P., Leary, S.L. and Mahowald, MX. (1985). Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J. Exp. Med., 162, 962–78PubMedCrossRefGoogle Scholar
  73. 73.
    Holmdahl, R., Olsson, T., Moran, T. and Klareskog, L. (1985). In vivo treatment of rats with monoclonal anti T cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis (EAN). Scand. J. Immunol., 22, 157–69Google Scholar
  74. 74.
    Lennon, V.A. and Byrd, W.J. (1973). Experimental arthritis in thymectomized rats with an impaired humoral immune response. Nature, 244, 38–40PubMedCrossRefGoogle Scholar
  75. 75.
    Holoshitz, J., Naparstek, Y., Ben-Nun, A. and Cohen, I.R. (1983). Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science, 219, 56–8PubMedCrossRefGoogle Scholar
  76. 76.
    Cohen, I.R., Ben-Nun, A., Holoshitz, J., Maron, R. and Zerubavel, R.L. (1984). Vaccination against autoimmune disease using lines of autoimmune T lymphocytes. Immunol. Today, 4, 227–30CrossRefGoogle Scholar
  77. 77.
    Fox, R., Sportsman, R., Rhodes, G., Luka, J., Pearson, G. and Vaughan, J. (1986). Rheumatoid arthritis synovial membrane contains a 62 000 molecular weight protein that shares an antigeni epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J. Clin. Invest., 77, 1539–47PubMedCrossRefGoogle Scholar
  78. 78.
    Steffen, C. (1970). Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity. Z. Immunol. Forsch., 139, 219–27Google Scholar
  79. 79.
    Wolf, B., Bashey, R.I., Newton, C.D. and Jimenez, S.A. (1986). Development of rheumatoid factors and anti-F(ab)2 antibodies in guineapigs immunized with type II bovine collagen. Int. Arch. Appl. Immunol., 80, 214–20CrossRefGoogle Scholar
  80. 80.
    Holmdahl, R., Tarkowski, A., Nordling, C, Rubin, K. and Klareskog, L. (1987). Connection between autoimmunity to cartilage collagen type II and rheumatoid factor production. In Bona, C. and Zanetti, M. (eds.) Idiotypes in Health and Disease. (In press)Google Scholar
  81. 81.
    Holmdahl, R., Nordling, C, Rubin, K., Tarkowski, A. and Klareskog, L. (1986). Generation of monoclonal rheumatoid factors (RF) after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is simultaneously a rheumatoid factor. Scand. J. Immunol., 24, 197–203PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1988

Authors and Affiliations

  • L. Klareskog
  • H. Wigzell

There are no affiliations available

Personalised recommendations